Antimicrobial-resistant infections
Conference Coverage
Daptomycin/fosfomycin: A new standard for MRSA bacteremia?
Better survival was seen for MRSA bacteremia at 7 days using the combo vs. monotherapy.
Conference Coverage
Stepdown to oral ciprofloxacin looks safe in gram-negative bloodstream infections
SAN FRANCISCO – A comparison of patients with gram-negative bloodstream infections showed low 90-day treatment...
Conference Coverage
In C. difficile, metronidazole may not benefit ICU patients on vancomycin
SAN FRANCISCO – Try fecal transplant instead.
Conference Coverage
ICU infections: Chlorhexidine wipes tame MRSA, CRE
SAN FRANCISCO – Decolonization tops precautions.
Conference Coverage
Point-of-care test for respiratory viruses lowers antibiotic use
PARIS – In patients presenting with respiratory infections, a point-of-care test for viral infections has been associated with a reduction in...
News from the FDA/CDC
FDA attacks antibiotic resistance with new strategy
Four-pronged approach addresses product development, stewardship, surveillance, and science.
From the Journals
NYC outbreak of Candida auris linked to 45% mortality
From the Journals
Piperacillin-tazobactam fails to outperform meropenem in bloodstream infections
Researchers are hoping for an alternative to meropenem because they fear more resistance will develop.
News from the FDA/CDC
CDC reports Salmonella outbreak
From the Journals
Urgent care and retail clinics fuel inappropriate antibiotic prescribing
Urgent care and retail clinics are “underrecognized” contributors to the ongoing problem of inappropriate antibiotic prescribing.
Conference Coverage
Primary cirrhotic prophylaxis of bacterial peritonitis falls short
A review of prospective data from 308 cirrhotic patients on antibiotic prophylaxis highlights the limitations of this treatment.